[ON THE PROBLEM OF PATHOGENESIS AND THERAPY OF LUPUS ERYTHEMATODES (ON THE EFFECTS OF TRIHYDROXYETHYLRUTOSID (VENORUTON P4))].
D000486:Allergy and Immunology; D000962:Antimalarials; D003095:Collagen Diseases; D005419:Flavonoids; D005853:Geriatrics; D006801:Humans; D006896:Hydroxyethylrutoside / Q000031:analogs & derivatives; D008179:Lupus Erythematosus, Discoid; D008180:Lupus Erythematosus, Systemic; D011241:Prednisone; D012431:Rutin
D000962:Antimalarials; D005419:Flavonoids; D006896:Hydroxyethylrutoside; D012431:Rutin; C005865:troxerutin; D011241:Prednisone
ANTIMALARIALS; BIOFLAVONOIDS; GERIATRICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREDNISONE; RUTIN
ZUR FRAGE DER PATHOGENESE UND THERAPIE DES LUPUS ERYTHEMATODES (UBER DIE WIRKUNG VON TRIHYDROXYAETHYLRUTOSID